CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha
about
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupUpstream open reading frames: molecular switches in (patho)physiologyGene expression regulation by upstream open reading frames and human diseaseOlean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (OEOA) induces G1 cell cycle arrest and differentiation in human leukemia cell linesAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) miceRestoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.Dysregulation of the C/EBPalpha differentiation pathway in human cancer.Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesThe Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.Apoptosis in leukemias: regulation and therapeutic targeting.Effects of PPARγ Ligands on Leukemia.Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C/EBPα and C/EBPβ mRNAsCDDO and Its Role in Chronic Diseases.Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα.C/EBPα deregulation as a paradigm for leukemogenesis.Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cellsBryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivoCDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice.2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
P2860
Q24602856-9D9D9D85-07C0-4CE1-A5DA-8BE12AD36BF0Q24614000-D80A2163-746A-4FD3-853B-BD00DE2E0CDCQ27693182-9E750AFB-9840-44ED-A34A-64B444ED1ABBQ28488148-3C1B42AC-14D6-4E8A-AD50-CABD88C74065Q33692555-32158269-722F-4C29-A29F-1598D23FBADDQ34412580-45334025-762F-46F6-B493-58FDB271E2C4Q36140549-F4402678-D927-47B8-A08D-7BD6B566EE49Q36293645-F4E856FA-4EA3-4762-A819-1C56CF3BD74CQ37104787-6CDD6430-F888-480B-B871-565DD2201188Q37182794-5E7F1567-0F03-45C0-86B7-FE4976FE7C43Q37616058-6805403A-B919-4CB7-9004-609CE64A2113Q37715814-A234DCDC-1FA7-4AD5-9402-50AE718D90CAQ38017661-6B735181-1163-4737-A029-751FD50C8DC5Q38411881-3C1DBD88-B336-4006-A532-6549CF440DFCQ38804023-DB6F549F-DAFC-4A4B-A380-CA71D055EC4BQ38807055-5972E815-4684-40D8-9C68-D9E180FDAA57Q39112113-22AFCDFE-56F9-4D35-89B7-038439BEFA9DQ39442731-17D65868-5246-4543-B697-8ECBFE3BEAF8Q39700405-2AFC265F-6017-4AFD-A38A-AE3D159BA5D4Q39919462-CA91303A-F5D5-4A80-826F-7EE3D2166875Q41879656-00DB70C7-3250-4714-AB71-7AC347473488Q42227825-0B675168-EFA9-4157-9CF6-1EF78D3E7B08Q42814347-56B7FB28-2E79-4635-8C5C-13A04E81C012Q50332120-BF129223-F22D-45DD-B71F-3C5B01A26357Q53264286-40496CF0-7393-4DC8-886D-D561E83AB91A
P2860
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@ast
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@en
type
label
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@ast
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@en
prefLabel
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@ast
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@en
P2093
P2860
P50
P1433
P1476
CDDO induces granulocytic diff ...... enhancer binding protein alpha
@en
P2093
Annalisa Di Ruscio
Bülent Sargin
Christine Schöneich
Daniel G Tenen
Danilo Perrotti
Elena Levantini
Francesco D'Alò
Hanna Radomska
Hubert Serve
Ji Suk Chang
P2860
P304
P356
10.1182/BLOOD-2006-11-058941
P407
P577
2007-08-01T00:00:00Z